| Name | Title | Contact Details |
|---|
Whitman Garvey is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 2004 by Rob Landerholm, MD FACS and Peter Billing, MD FACS, Eviva set out to provide excellence in patient care with a focus on leading edge bariatric (weight loss) surgery. Prominently known as industry leaders in bariatrics, Eviva has also maintained steady growth in a variety of services. The objective of our founding surgeons has come to fruition and we are pleased to have acquired a growing team of physicians and specialized care providers who share the same goals. We are leaders in performing advanced laparoscopic surgical procedures as well as a variety of specialty and preventative care services. Surgical care options include bariatric surgery, orthopedic surgery, hand surgery, cosmetic surgery, general surgery and more. Our comprehensive bariatric surgery program sets a new paradigm, providing personalized care and education prior to surgery thus maximizing patient success with our complete bariatric aftercare program. Our bariatric team is comprised of various care professionals focused on the medical, nutritional, fitness and mental health of each patient.
Hi-Vision America Inc is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Microvision Optical, Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe